Crescita Therapeutics Inc (CTX) — Cash Flow-to-Debt Ratio
Crescita Therapeutics Inc (CTX) has a Cash Flow-to-Debt Ratio of 0.09x as of December 2025, meaning its operating cash flow of CA$416.00K could theoretically repay 0% of its total liabilities (CA$4.75 Million) in one year. Explore how much of Crescita Therapeutics Inc's assets are long-term investments to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Crescita Therapeutics Inc Cash Flow-to-Debt Ratio (2014–2025)
Historical debt coverage capacity for Crescita Therapeutics Inc across 12 annual periods. Also explore balance sheet size of Crescita Therapeutics Inc for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Crescita Therapeutics Inc (2014–2025)
Year-by-year debt coverage analysis for Crescita Therapeutics Inc. For market capitalisation and broader financial context, see how much is Crescita Therapeutics Inc worth.
| Year | CF-to-Debt Ratio | Operating CF (CAD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.23x | CA$1.07 Million | CA$4.75 Million | ▼ -50.7% |
| 2024 | 0.46x | CA$2.73 Million | CA$5.95 Million | ▲ +27.5% |
| 2023 | 0.36x | CA$2.08 Million | CA$5.78 Million | ▲ +360.3% |
| 2022 | -0.14x | CA$-1.02 Million | CA$7.39 Million | ▲ +27.4% |
| 2021 | -0.19x | CA$-1.60 Million | CA$8.40 Million | ▼ -119.3% |
| 2020 | 0.98x | CA$5.61 Million | CA$5.70 Million | ▲ +6.3% |
| 2019 | 0.93x | CA$5.31 Million | CA$5.73 Million | ▲ +636.3% |
| 2018 | -0.17x | CA$-1.48 Million | CA$8.56 Million | ▲ +77.9% |
| 2017 | -0.78x | CA$-7.40 Million | CA$9.46 Million | ▲ +31.7% |
| 2016 | -1.15x | CA$-18.58 Million | CA$16.21 Million | ▲ +62.5% |
| 2015 | -3.06x | CA$-13.92 Million | CA$4.55 Million | ▼ -22.8% |
| 2014 | -2.49x | CA$-9.30 Million | CA$3.74 Million | — |